Stem cell treatment for ALS is proving safe in study

01/17/2012 | Reuters

BrainStorm Cell Therapeutics said the initial results of a clinical trial showed that its adult stem cell therapy NurOwn was safe for patients with amyotrophic lateral sclerosis. The study involved the transplant of cells derived from the patients' bone marrow. Researchers are preparing to expand the trial to determine the treatment's efficacy.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC